A detailed history of Gamma Investing LLC transactions in Novavax Inc stock. As of the latest transaction made, Gamma Investing LLC holds 46 shares of NVAX stock, worth $611. This represents 0.0% of its overall portfolio holdings.

Number of Shares
46
Previous 100 54.0%
Holding current value
$611
Previous $478,000 21.76%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 02, 2024

SELL
$3.89 - $20.97 $210 - $1,132
-54 Reduced 54.0%
46 $582,000
Q1 2024

Apr 05, 2024

BUY
$3.76 - $6.02 $376 - $602
100 New
100 $478,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $1.04B
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.